Rallybio (RLYB) announced the publication of a manuscript titled, “Informing Pregnancy Dose via Target-Mediated Drug Disposition Modeling and ...

AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

Cancer treatment has entered a revolutionary phase with advancements in immunotherapy, a field that employs the immune system ...

(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...